Ask AI
ProCE Banner Activity

The Next Chapter in CSU: Expert Dialogues in Diagnosis and Leveraging New and Emerging Therapies

Slideset

Expert-curated slides on the burden of chronic spontaneous urticaria (CSU), best practices in diagnosing and managing CSU, and the latest data on emerging therapies.

Released: April 16, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Target Audience

This activity is intended for allergy/immunology and dermatology healthcare professionals, including physicians, residents, fellows, nurse practitioners, and physician associates, and others who care for patients with CSU.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify key cellular and molecular mechanisms involved in the pathophysiology of CSU 

  • Characterize factors contributing to the burden of living with CSU

  • Design evidence-based diagnostic and assessment plans for all patients with CSU

  • Evaluate recent clinical data on available and emerging therapies for patients with CSU